Portfolio company
1nhaler
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
1nhaler develops sustainable cardboard dry powder inhalers for pharmaceutical companies to deliver treatments for conditions such as asthma, allergies and epilepsy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Softhale
This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.
Aflo Analytics
This company develops a digital platform and connected sensor that monitors inhaler technique and adherence for patients with respiratory conditions and their clinicians.
Aetherus
Aetherus develops a handheld, non-invasive breathing device providing rapid relief from breathlessness for patients suffering from chronic obstructive pulmonary disease.
Misti
Misti develops customisable nebuliser technology to deliver medicines to the lungs of children and older adults with respiratory diseases.
Nebu-Flow
The company develops nebuliser technology for pharmaceutical partners to deliver biologic drugs and other formulations to the lungs of patients with respiratory disorders.
Iconovo
This company develops inhalation devices and dry powder formulations for pharmaceutical partners to create new and generic inhaled medicines.
Eco-Inject
The company manufactures bio-based, single-use autoinjector devices for pharmaceutical and biotechnology firms to deliver injectable therapies with a reduced carbon footprint.
Aluna
Aluna develops a digital spirometer and monitoring platform for patients and doctors to manage chronic respiratory conditions like asthma and COPD.
